Risk factors for severe rhino-orbital mucormycosis during its epidemic post-COVID-19 pandemic

Indian J Public Health. 2022 Oct-Dec;66(4):494-497. doi: 10.4103/ijph.ijph_714_22.

Abstract

Postsecond wave of COVID-19 pandemic in the year 2021, rhino-orbital mucormycosis (ROM) was seen as an epidemic in the Indian community. Severe ROM disease has poor prognosis and requires a multidisciplinary approach for treatment. Hence, its prevention is better than cure. Studies done during the epidemic assessed predisposing factors, but this was a novel study which focused on assessing risk factors for severe disease of ROM. Ninety-four consecutive patients of ROM admitted at our designated nodal tertiary hospital of North India were enrolled, and data were collected and analyzed. Facial edema was the most common presenting complaint. Subclinical and mild COVID-19 infection was associated with severe ROM. Uncontrolled diabetes mellitus and prophylactic zinc supplementation were other significant risk factors for severe ROM. Public awareness among the general population for the above risk factors can prevent a debilitating disease like severe ROM.

Keywords: COVID-19 pandemic; epidemic; rhino-orbital mucormycosis; risk factors.

MeSH terms

  • COVID-19*
  • Humans
  • India / epidemiology
  • Mucormycosis* / epidemiology
  • Pandemics
  • Risk Factors